Abbott's Absorb GT1 Is First FDA-Approved Absorbable Coronary Stent

Following the near-unanimous advice of its advisory panel, the US FDA approved Abbott Laboratories’ Absorb GT1 everolimus-eluting biodegradable poly(L-lactide) scaffold, making it the first bioresorbable coronary stent commercially available in the US.